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Attributable Costs of Surgical Site Infection and Endometritis
after Low Transverse Cesarean Delivery
Margaret A. Olsen, PhD, MPH; Anne M. Butler, MS; Denise M. Willers, MD; Gilad A. Gross, MD;
Barton H. Hamilton, PhD; Victoria J. Fraser, MD

background. Accurate data on costs attributable to hospital-acquired infections are needed to determine their economic impact and
the cost-benefit of potential preventive strategies.
objective. To determine the attributable costs of surgical site infection (SSI) and endometritis (EMM) after cesarean section by means
of 2 different methods.
design.
setting.
patients.

Retrospective cohort.
Barnes-Jewish Hospital, a 1,250-bed academic tertiary care hospital.
There were 1,605 women who underwent low transverse cesarean section from July 1999 through June 2001.

methods. Attributable costs of SSI and EMM were determined by generalized least squares (GLS) and propensity score matched-pairs
by means of administrative claims data to define underlying comorbidities and procedures. For the matched-pairs analyses, uninfected
control patients were matched to patients with SSI or with EMM on the basis of their propensity to develop infection, and the median
difference in costs was calculated.
results. The attributable total hospital cost of SSI calculated by GLS was $3,529 and by propensity score matched-pairs was $2,852.
The attributable total hospital cost of EMM calculated by GLS was $3,956 and by propensity score matched-pairs was $3,842. The majority
of excess costs were associated with room and board and pharmacy costs.
conclusions. The costs of SSI and EMM were lower than SSI costs reported after more extensive operations. The attributable costs
of EMM calculated by the 2 methods were very similar, whereas the costs of SSI calculated by propensity score matched-pairs were lower
than the costs calculated by GLS. The difference in costs determined by the 2 methods needs to be considered by investigators who are
performing cost analyses of hospital-acquired infections.
Infect Control Hosp Epidemiol 2010; 31:276-282

Surgical site infections (SSIs) are associated with substantial
morbidity, longer hospital length of stay, and hospital readmissions.1-3 Most estimates for the costs of SSI come from
older studies that used simple statistical methods or no statistical comparisons, with only crude estimates for the attributable costs of infection. Attributable costs can vary depending on the type of statistical method used, as shown by
Hollenbeak et al4 for the costs of SSI after coronary artery
bypass surgery.
In many studies, attributable costs were calculated for SSI
that occurred after a variety of different operations, rather
than calculated for SSI after individual surgical procedures.5-10
Not all SSIs are alike, however. SSIs after operations involving
major organ spaces, such as cardiac or orthopedic surgery,
may very well have higher attributable costs than do SSIs

after less extensive operations.4,11,12 In addition, costs of SSI
likely vary according to the depth of the infection. Attributable costs of SSIs have been reported to be highest for
organ-space infection, compared with attributable costs of
deep incisional or superficial incisional SSIs.2,13-15
Accurate estimates of the attributable costs of SSI are
needed, from the hospital perspective, to weigh the cost-benefit of infection prevention strategies and to determine the
impact of the Deficit Reduction Act and the ruling by the
Centers for Medicare and Medicaid Services. This ruling,
which went into effect in October 2008, denies upgrade to
the higher diagnosis-related group for secondary diagnoses
considered to be “preventable hospital-acquired conditions,”
including some SSIs.16
Most studies that examined hospital costs associated with
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table 1. Selected Characteristics of the Low Transverse Cesarean Section Cohort at Barnes-Jewish Hospital, 1999–2001 (n
p 1,597)
Characteristic
Age, mean Ⳳ SD, years
BMI, mean Ⳳ SD
Race
White
Black
Other
Absence of private health insuranceb
Antepartum hemorrhage
Postpartum hemorrhage
Coagulation and hemorrhagic disorders
Chorioamnionitis
Pelvic inflammatory disease
Gonorrhea or syphilis
Group B Streptococcus
Sepsis
Urinary tract or kidney infectionc
Renal disease
Pneumonia
Pulmonary collapse or insufficienciesd
Maternal cardiac conditions
Diabetes mellitus
Gestational diabetes
Pre-eclampsia, mild
Pre-eclampsia, severe
Eclampsia
Premature rupture of membranes
Multiple gestation
Obstetric laceration and/or trauma
Severe complication of delivery
Fetal distress
Intrauterine fetal death
Failed labor
Malposition and malpresentation of fetus
Previous cesarean section
Amnioinfusion
Labor induction
Ovarian procedure
Tubal ligation
Laparotomy
Tracheostomy ventilation
Central venous cathetere

No SSI or EMM
(n p 1,415)

SSI
(n p 80)

27.2 Ⳳ 6.5
33.7 Ⳳ 7.8
471 (33.3)
870 (61.5)
74 (5.2)
825 (58.3)
42 (3.0)
57 (4.0)
27 (1.9)
133 (9.4)
23 (1.6)
16 (1.1)
57 (4.0)
7 (0.5)
44 (3.1)
12 (0.8)
15 (1.1)
20 (1.4)
40 (2.8)
59 (4.2)
104 (7.3)
96 (6.8)
126 (8.9)
11 (0.8)
58 (4.1)
89 (6.3)
24 (1.7)
19 (1.3)
589 (41.6)
9 (0.6)
288 (20.4)
367 (25.9)
446 (31.5)
131 (9.3)
249 (17.6)
8 (0.6)
269 (19.0)
3 (0.2)
5 (0.4)
17 (1.2)

26.7 Ⳳ 6.4
36.9 Ⳳ 9.1
29 (36.3)
46 (57.5)
5 (6.3)
50 (62.5)
2 (2.5)
7 (8.8)
1 (1.3)
17 (21.3)
1 (1.3)
0 (0)
8 (10.0)
3 (3.8)
4 (5.0)
0 (0)
3 (3.8)
4 (5.0)
4 (5.0)
4 (5.0)
4 (5.0)
10 (12.5)
6 (7.5)
1 (1.3)
2 (2.5)
6 (7.5)
1 (1.3)
2 (2.5)
43 (53.8)
1 (1.3)
20 (25.0)
25 (31.3)
25 (31.3)
12 (15.0)
20 (25.0)
3 (3.8)
17 (21.3)
5 (6.3)
3 (3.8)
1 (1.3)

P, SSI vs
control patientsa
.498
!.001

…
.532
.853
.459
1.99
.078
1.99
.001
.787
1.99
.020
.013
.321
1.99
.067
.036
.292
.576
.430
.053
.667
.484
.768
.666
1.99
.311
.033
.424
.317
.293
.960
.089
.094
.018
.620
!.001
.007
1.99

EMM
(n p 121)
23.2 Ⳳ 5.8
34.9 Ⳳ 8.6
22 (18.2)
97 (80.2)
2 (1.7)
94 (77.7)
5 (4.1)
6 (5.0)
1 (0.8)
26 (21.5)
0 (0)
1 (0.8)
4 (3.3)
4 (3.3)
8 (6.6)
0 (0)
3 (2.5)
0 (0)
7 (5.8)
7 (5.8)
6 (5.0)
19 (15.7)
13 (10.7)
1 (0.8)
11 (9.1)
3 (2.5)
2 (1.7)
4 (3.3)
68 (56.2)
1 (0.8)
44 (36.4)
28 (23.1)
16 (13.2)
29 (24.0)
37 (30.6)
1 (0.8)
10 (8.3)
3 (2.5)
1 (0.8)
4 (3.3)

P, EMM vs
control patientsa
!.001

.105
…
!.001

.465
!.001

.412
.630
.720
!.001
.250
1.99
1.99
.008
.060
.615
.164
.396
.090
.400
.328
!.001
.499
1.99
.011
.090
1.99
.101
.002
.561
!.001
.499
!.001
!.001
!.001
.523
.003
.008
.389
.077

note. Data are no. (%) of patients, unless otherwise indicated. BMI, body mass index; EMM, endometritis; SD, standard deviation; SSI,
surgical site infection.
a
Comparison vs uninfected control group.
b
Presence of public aid, Medicare, Medicaid, or no insurance.
c
Diagnosed on or after the day of cesarean section.
d
Atelectasis, pulmonary edema, acute respiratory distress syndrome, or respiratory failure.
e
Inserted before the onset of SSI and/or EMM in case patients.

SSI have determined total hospital costs attributable to infection. More recently, an argument has been made to focus
on direct costs (primarily consumables), because they are
most subject to savings by implementation of effective infection control interventions.17,18 On the other hand, fixed

costs, such as costs for most nursing staff, electricity, and
maintenance, are not subject to immediate savings through
prevention of infection. Therefore, calculation of the attributable direct costs of SSI may be necessary to inform costbenefit analyses of infection control interventions.
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table 2. Crude Costs Associated With Surgical Site Infection (SSI) and Endometritis (EMM)
in the Cohort Population
US $2008, median (range)a
SSI
(n p 80)

Cost
Total
Room and board
Pharmacy
Laboratory
Otherb

10,317
7,419
1,722
398
503

(4,703–140,478)
(3,054–73,447)
(200–28,571)
(44–32,908)
(0–22,296)

EMM
(n p 121)
11,141
7,015
2,627
618
498

(4,248–57,263)
(2,960–25,455)
(343–13,012)
(43–10,771)
(0–4,505)

No SSI or EMM
(n p 1,415)
6,829
5,762
593
227
115

(1,642–277,573)
(1,192–87,004)
(0–39,632)
(0–32,908)
(0–41,172)

a
Median costs for the radiology, respiratory therapy, and physical therapy departments were zero for all
SSI case patients, EMM case patients, and uninfected control patients. For all comparisons, P ! .001 by
Mann-Whitney U test.
b
Includes all costs not allocated to room and board, pharmacy, laboratory, radiology, respiratory therapy,
or physical therapy departments.

We used administrative claims data from a retrospective
cohort of women who underwent low transverse cesarean
section at our academic tertiary care hospital and 2 different
statistical methods to determine the attributable total and
direct costs for SSI and endometritis (EMM).

methods
This study was conducted at Barnes-Jewish Hospital, a 1,250bed tertiary care hospital affiliated with Washington University School of Medicine in Saint Louis, Missouri. All patients
who underwent low transverse cesarean section surgery, defined by an International Classification of Diseases, Ninth Edition, Clinical Modification (ICD-9-CM) procedure code for
low transverse cesarean section (74.1), from July 1, 1999,
through June 30, 2001, were eligible for the study. For inclusion, patients were required to have an operative note that
indicated use of a low transverse uterine incision. Potential
SSI and EMM case patients were identified using ICD-9-CM
discharge diagnosis codes consistent with incisional infection
(998.50, 998.51, 998.59, 674.32, or 674.34) or EMM (670.02
or 670.04) during the original surgical admission or at readmission (inpatient, outpatient surgery, or emergency room)
to the hospital within 60 days of surgery and/or excess antibiotics utilization after surgery, as described previously.19-22
Excess antibiotics utilization was defined as 2 or more days
of antibiotics beginning with postoperative day 2, or any
antibiotics at readmission to the hospital within 60 days of
surgery. Hospital medical records were reviewed for all patients who met the ICD-9-CM or antibiotics criteria, and signs
and symptoms of infection were recorded. EMM was defined
as fever beginning more than 24 hours or continuing at least
24 hours after delivery plus fundal tenderness.22 SSIs were
verified by chart review in accordance with the Centers for
Disease Control and Prevention National Nosocomial Infections Surveillance system definitions.21,23 During the period
of this study, routine prophylactic antibiotics (cefazolin or
cefotetan) were given at cord clamp.21
Demographic information, microbiology and laboratory

results, and ICD-9-CM diagnosis and procedure codes were
collected for the original surgical admission by means of the
Barnes-Jewish Hospital Medical Informatics database. ICD9-CM diagnosis codes used to identify underlying comorbidities were also collected for the 12 months preceding the
date of surgery. Comorbidity and procedure variables were
created from claims data with the Healthcare Cost and Utilization Project Clinical Classifications Software.24
Hospital cost data were obtained from the Barnes-Jewish
Hospital cost accounting database (Trendstar; McKesson) for
the surgical admission and any inpatient, outpatient surgery,
and emergency readmission to the hospital within 30 days
after surgery, excluding the costs and hospital days before the
day of the cesarean section. Costs were calculated for each
department (eg, room and board or pharmacy) by multiplying the department’s actual cost components by the charges
for each patient charge code recorded during hospitalizations,
divided by total departmental costs. Departmental costs were
summed to calculate total hospital costs for each patient. All
costs were inflation adjusted to 2008 US dollars by means of
the medical care component of the Consumer Price Index.25
Patient characteristics were compared by the Student t test,
x2 test, or Fisher exact test, as appropriate. Crude costs were
compared by the Mann-Whitney U test. Generalized least
squares (GLS) models were fit to estimate the costs associated
with SSI and EMM (the primary independent variables),
while taking into account the variation of other factors significantly associated with costs. Frequency analyses were performed on the claims data to identify diagnoses and procedures that might be important predictors of cost. Variables
that applied to fewer than 10 patients were excluded. Linearity
assessments were performed for continuous variables. The
natural log of total costs was used as the dependent variable
to normalize the highly skewed distribution, and an estimator
(“feasible GLS estimator”) was used to weight the observations to account for heteroskedasticity.26 The multivariate GLS
model was determined by evaluating all biologically plausible
variables, with use of P X .05 for entry and P 1 .20 for ex-
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table 3. Results of the Generalized Least Squares Model for Determining Attributable
Costs of Surgical Site Infection (SSI) and Endometritis (EMM) After Low Transverse
Cesarean Section (n p 1,597)
Variable
Variable of interest
SSI
EMM
Demographic characteristic
Age !18 years
Age 135 years
Absence of private insurancea
Procedure
Labor induction
Ovarian procedure
Central venous catheterb
Medical condition
Antepartum hemorrhage
Postpartum hemorrhage
Coagulation and hemorrhagic disorders
Chorioamnionitis
Pelvic inflammatory disease
Gonorrhea or syphilis
Urinary tract or kidney infectionc
Pneumonia
Pulmonary collapse or insufficienciesd
Maternal cardiac conditions
Diabetes mellitus or gestational diabetes
Pre-eclampsia (mild)
Pre-eclampsia (severe)
Eclampsia
Multiple gestation
Obstetric laceration and/or trauma
Severe complication of delivery
Fetal distress
Intrauterine fetal death

Proportion
of patients

Estimated
b coefficient

SE

P

0.05
0.08

0.36
0.39

0.03
0.03

!.001
!.001

0.05
0.13
0.60

0.06
0.04
0.02

0.03
0.02
0.02

.088
.106
.192

0.19
0.01
0.01

0.04
0.26
0.51

0.02
0.08
0.07

.040
.002
!.001

0.03
0.04
0.02
0.11
0.02
0.01
0.03
0.01
0.02
0.03
0.11
0.08
0.09
0.01
0.06
0.02
0.02
0.43
0.01

0.09
0.10
0.08
0.15
0.12
0.13
0.11
0.37
0.16
0.13
0.05
0.10
0.23
0.62
0.10
0.20
0.53
0.02
0.19

0.04
0.04
0.06
0.02
0.06
0.07
0.04
0.07
0.06
0.04
0.02
0.03
0.03
0.08
0.03
0.06
0.06
0.02
0.09

.032
.008
.135
!.001
.049
.060
.009
!.001
.010
.002
.022
!.001
!.001
!.001
.001
.001
!.001
.149
.040

note.

Adjusted R2 p 0.24 for the model after accounting for natural log transformation of costs.
SE, standard error.
a
Presence of public aid, Medicare, Medicaid, or no health insurance.
b
Inserted before the onset of SSI and/or EMM in case patients.
c
Diagnosed on or after the day of cesarean section.
d
Atelectasis, pulmonary edema, acute respiratory distress syndrome, or respiratory failure.

clusion. All independent variables were checked for collinearity. Models were checked for functional form misspecification by means of the Ramsey regression specification error
test and for heteroskedasticity by means of the Breusch-Pagan
test.26 Because the GLS model used the natural logarithm of
costs as the dependent variable, an intermediate regression
was performed to predict costs in US dollars.26
Each coefficient obtained in the GLS model represented
the mean difference in the natural logarithm of costs between
individuals with and without that variable, assuming all other
predictors of costs remained constant. To calculate the attributable costs of SSI and EMM, the regression equation was
solved separately for (1) patients with SSI, (2) patients with
EMM, and (3) patients without infection, and was back trans-

formed by exponentiating the result. The attributable costs
of SSI and EMM were calculated by subtracting the difference
in calculated costs between women with SSI or EMM and
women without infection.
The second method for determining attributable costs of
SSI and EMM was a propensity score matched-pairs analysis.27
A logistic regression model was created to predict the probability of developing SSI. The model was adjusted for all
variables suspected to affect the risk of developing SSI, as
defined by P ! .20 in univariate analysis or biologic plausibility. SSI case patients and control patients were matched 1
: 1 on the basis of their propensity to develop SSI by means
of the nearest-neighbor method within calipers of 0.10 standard deviations.28 SSI case patients without a suitable control
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table 4. Attributable Total Costs of Surgical Site Infection and
Endometritis After Low Transverse Cesarean Section Calculated by
2 Different Methods
Adjusted cost in US $2008, median (95% CI)
Method

Surgical site
infection

Endometritis
a

GLS
$3,529 ($3,105–$4,011) $3,956 ($3,481–$4,496) a
Matched-pairs $2,852 ($2,006–$4,378)b $3,842 ($3,254–$5,111)b
note.

CI, confidence interval; GLS, generalized least squares.
Estimates adjusted for covariates in Table 3.
b
Costs are the medians and 95% CIs based on the binomial distribution.
The medians were used for the matched-pairs analyses because the cost
differences were not normally distributed.
a

patient were excluded from the analysis. Comparisons were
performed between unmatched and matched SSI case patients
by means of the x2 or Fisher exact test, with correction for
multiple testing (a/number of tests). These methods were
repeated to create propensity score matched-pairs for EMM
case patients and control patients. Attributable costs were
calculated as the median of the differences in cost between
matched-pairs. The median difference in cost was compared
with the Wilcoxon signed-rank test, with 95% confidence
intervals [CIs] calculated in Stata.
Statistical analyses were performed using SPSS, version 14.0
(SPSS), and Stata, version 9.2 (StataCorp). Approval for this
study was obtained from the Washington University Human
Research Protection Office.

results
Of 1,605 patients who underwent low transverse cesarean
section during the study period, complete cost data was available for 1,597 patients (99.5%). Cost data was missing for 1
patient with both SSI and EMM, 2 patients with EMM, and
5 patients without infection. Characteristics of the low transverse cesarean section cohort with complete cost data are
shown in Table 1. Eighty patients (5.0%) developed SSI and
121 (7.6%) developed EMM, including 19 patients (1.2%)
with both SSI and EMM. SSI case patients had significantly
higher body mass index and were significantly more likely to
have ICD-9-CM diagnosis codes for chorioamnionitis, mild
pre-eclampsia, fetal distress, pulmonary collapse or insufficiencies (atelectasis, pulmonary edema, acute respiratory distress syndrome, or respiratory failure), group B Streptococcus
infection, or sepsis and to have ICD-9-CM procedure codes
for an ovarian operation, laparotomy, or tracheostomy and/
or mechanical ventilation. Compared with patients without
infection, women with EMM were younger, more likely to
be African American, and less likely to have private medical
insurance. Patients with EMM were significantly more likely
to have ICD-9-CM diagnosis codes for chorioamnionitis, sepsis, mild pre-eclampsia, fetal distress, premature rupture of
membranes, or failed labor and to have ICD-9-CM procedure
codes in the surgical admission for amnioinfusion, labor in-

duction, and laparotomy. EMM occurred significantly less
often in patients who had undergone a previous cesarean
section or who had tubal ligation at the time of the cesarean
section. The median length of surgical stay, beginning with
the day of cesarean section, was significantly longer for women
with SSI (4.5 days) or EMM (5.4 days), compared with the
corresponding stay for uninfected control patients (4.0 days;
P ! .001 for both).
Table 2 presents crude hospital costs for SSI and EMM
case patients and uninfected patients. Patients with SSI or
EMM had significantly higher unadjusted costs for the surgical admission plus any readmission within 30 days of surgery, compared with such costs for uninfected patients
(P ! .001 for both). Room and board, pharmacy, and laboratory departmental costs were also significantly higher for
SSI and EMM case patients, compared with such costs for
uninfected patients (P ! .001 for all). The crude increases in
length of hospital stay (beginning with the date of surgery
and including length of stay during hospital readmissions that
began within 30 days after surgery) were 2.2 days for SSI and
1.8 days for EMM (P ! .001 for both, Mann-Whitney U test).
Both SSI and EMM were independent predictors of hospital
costs (P ! .001) in the GLS model (Table 3). Procedures associated with significantly increased costs included labor induction, ovarian procedures, and placement of a central venous catheter. Other medical conditions that strongly affected
costs included severe complications of delivery, pneumonia,
pulmonary collapse or insufficiencies, intrauterine fetal death,
chorioamnionitis, maternal cardiac conditions, and obstetric
laceration and/or trauma. There was an increasing dose-response relationship between costs and mild pre-eclampsia,
severe pre-eclampsia, and eclampsia, as indicated by the progressively larger values for the b coefficients.
The attributable costs of SSI and EMM estimated by GLS
are presented in Table 4. After adjustment for the variables
listed in Table 3, the attributable total costs estimated by GLS
were $3,529 for SSI and $3,956 for EMM. In a separate analysis, the estimated attributable direct cost was $2,054 (95%
CI, $1,797–$2,347) for SSI and $2,726 (95% CI, $2,386–
$3,116) for EMM.
In the propensity score matched-pairs analyses, 68 of the
80 SSI case patients were matched with control patients and
110 of the 121 EMM case patients were matched with control
patients. Twelve SSI case patients and 11 EMM case patients
were excluded because a nearest-neighbor control was not
available. All covariates were balanced between matched SSI
case patients and control patients and matched EMM case
patients and control patients after controlling for multiple
comparisons. Unmatched SSI case patients had significantly
higher median total costs, compared with those for matched
SSI case patients ($16,088 vs $9,973; P p .008). Costs were
not significantly different for unmatched versus matched
EMM case patients ($10,262 vs $11,346; P p .540).
The median difference in total costs between the matched
SSI case and control pairs was $2,852, and the median dif-
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ference in direct costs was $1,675 (P ! .001, Wilcoxon signedrank test). The median difference in total costs between the
matched EMM case and control pairs was $3,842, and the
median difference in direct costs was $2,357 (P ! .001, Wilcoxon signed-rank test). The median difference in the hospital
length of stay (beginning with the date of surgery through
the date of discharge, plus inpatient readmissions that began
within 30 days after surgery) for the matched pairs was 2.0
days for SSI and 1.8 days for EMM (P ! .001 for both, Wilcoxon signed-rank test).

discussion
We used 2 different statistical methods to calculate attributable total and direct costs associated with SSI and EMM.
We found that the attributable costs of EMM calculated by
GLS and propensity score matched-pairs were virtually the
same (approximately $3,900), whereas the attributable costs
of SSI calculated by GLS ($3,529) were higher than the costs
calculated by the matched-pairs method ($2,852).
GLS modeling is commonly used for econometric analyses
but relies on the careful specification of the model and inclusion of factors associated with both hospital costs and
infection to reduce bias of the estimates. The advantage of
the propensity score matched-pairs method is that costs are
compared for individuals with similar likelihood of developing infection, and the difference in costs should therefore
represent the true incremental costs of diagnosing and treating the infection. The disadvantage of this method is the loss
of infected case patients due to the inability to find suitable
matched control patients with equivalent likelihood of developing infection. The unmatched case patients tend to be
individuals with very high probability of infection, because
not as many uninfected patients have high probabilities of
infection. Thus, the attributable costs calculated with this
method exclude the sicker patients with more underlying
comorbidities, and the calculated costs tend to be lower than
the costs calculated by GLS. This was true for the attributable
costs of SSI; in contrast, the attributable costs of EMM calculated with the 2 methods were remarkably similar.
The attributable total costs of SSI after cesarean section
calculated in this study (approximately $3,500) were lower
than costs of SSI reported in most previous studies following
other operations (range, approximately $3,400–$17,700).3-6,
11,12,29
It is not surprising that the total costs we calculated for
cesarean section SSIs are on the low end of the scale of reported SSI costs, because the SSIs were primarily superficial
incisional infections treated with antibiotic therapy and/or
local wound care. To our knowledge, there is only one other
report of the crude costs of SSI after cesarean section. Mugford et al30 found that SSI added £716 (1986–1987 British
pounds), which translates to $2,435 in US 2008 dollars,31
consistent with our findings.
Our calculation of $3,956 in attributable total costs due to
EMM was higher than the costs estimated in previous studies.
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To our knowledge, there are only 2 published reports of costs
associated with EMM; one reported in 1980 calculated costs
of $850 in a matched-pairs analysis (approximately $3,085 in
US 2008 dollars25), and the other more recent study estimated
costs of $815 in 2001 US dollars ($688 for treatment of EMM
plus $126 for fever evaluation, approximately $1,087 in US
2008 dollars) due to EMM after elective cesarean section
based on decision tree analysis.32 It is unclear from this analysis, however, whether costs associated with excess length of
stay were included in the attributable costs.
In the study by Mugford et al,30 76% of the excess costs
due to SSI resulted from staffing due to longer length of
hospital stay in patients with infection. In our study, room
and board costs were also the biggest driver of increased crude
costs for women with SSI, whereas pharmacy costs made the
largest contribution to increased costs for women with EMM.
Excess room and board costs were responsible for 48% of
the increased crude costs in patients with SSI and 29% of the
increased crude costs in women with EMM, compared with
the crude costs of uninfected women. Pharmacy costs made
up 32% of the increased crude costs for women with SSI and
47% of the increased crude costs for women with EMM,
compared with the crude costs of women without infection.
Thus, although the attributable costs of the 2 infections were
very similar, the cost centers driving the increase for the 2
infections were different. In contrast to the 12% higher attributable total costs of EMM, compared with those of SSI
($3,956 vs $3,529), the attributable direct cost of EMM estimated with GLS was 33% higher than the direct cost of SSI
($2,726 vs $2,054 direct cost for SSI). This is consistent with
the finding that pharmacy costs (74% of which were direct
costs) contributed more to the total crude costs of EMM. In
contrast, room and board costs made up a higher percentage
of the total crude costs of SSI, and a much smaller proportion
of the room and board costs were in the direct cost category
(40% direct costs).
The limitations of this study are the focus on hospital costs
of infection, rather than total costs from a societal perspective,
including costs of additional clinic visits, outpatient antibiotic
therapy, home health visits, and so forth. We excluded SSIs
that were diagnosed and treated solely in the outpatient setting, because those infections would not be associated with
increased hospital costs. We expect that the exclusion of outpatient infections has minimal impact on the costs of EMM,
because patients with EMM are almost always hospitalized
for intravenous antibiotic therapy.
In summary, we used 2 different methods to calculate hospital costs attributable to SSI and EMM after low transverse
cesarean section. The costs of EMM calculated by the 2 methods were very similar, whereas the cost of SSI calculated by
GLS was higher than the cost calculated using propensity
score matched pairs. Investigators can use these results to
determine the most appropriate method for calculation of
attributable costs on the basis of the goal of their cost analyses.
The results of this study can be used to determine the cost-
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benefit of routine prophylactic antibiotic administration and
other infection control interventions to prevent postoperative
infection after cesarean section.
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